SPERM Share Price Performance
Recent SPERM News & Updates
No updates
Spermosens AB Key Details
Last Reported Earnings
Mar 31, 2025
Next Reporting Earnings
Aug 20, 2025
- Earnings per share (EPS)
- -0.0029
- Gross Margin
- 0%
- Net Profit Margin
- 0%
- Debt/Equity Ratio
- 0.2%
Spermosens AB Competitors
About SPERM
- Founded
- 2018
- Employees
- 3
- CEO
- WebsiteView website
Spermosens AB provides diagnostic health care products and services in Sweden. The company offers male infertility fertility diagnostics and fertility treatments for the IVF market. It develops JUNO-Checked, a device that measures the binding between sperm and egg cell to enable individualized choice of fertility treatment based on measured binding. Spermosens AB was incorporated in 2018 and is based in Lund, Sweden.
Swedish Market Performance
- 7 Days: -3.5%
- 3 Months: 1.1%
- 1 Year: -0.4%
- Year to Date: -1.5%
Over the last 7 days, the market has dropped 3.5%, driven by losses in every sector, especially the Industrials sector. Although the market performance has been flat over the past year. Looking forward, earnings are forecast to grow by 17% annually. Market details ›
This week, we’re diving deeper into the world of agentic AI. We’re zeroing in on the core technologies that make these intelligent agents actually reliably work. We explore what all this could mean for software, start-ups, and most importantly, the opportunities and risks each industry faces by adopting Agentic AI.
Continue reading